BLISS GVS PHARMA
Back to All Ratios
|
BLISS GVS PHARMA Last 5 Year Return on Capital Employed (ROCE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| ROCE(%) | 12.29 | 12.15 | 12.22 | 6.37 | 12.49 |
What is the latest Return on Capital Employed (ROCE) ratio of BLISS GVS PHARMA ?
| Year | Return on Capital Employed (ROCE) |
|---|---|
| Mar2025 | 12.29 |
| Mar2024 | 12.15 |
| Mar2023 | 12.22 |
| Mar2022 | 6.37 |
| Mar2021 | 12.49 |
How is Return on Capital Employed (ROCE) of BLISS GVS PHARMA Trending?
| Years | Return on Capital Employed (ROCE) | % Change | |
|---|---|---|---|
| Mar2025 | 12.29 | 1.15 | |
| Mar2024 | 12.15 | -0.57 | |
| Mar2023 | 12.22 | 91.84 | |
| Mar2022 | 6.37 | -49.00 | |
| Mar2021 | 12.49 | - | |
Other Financial Ratios of BLISS GVS PHARMA
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹1,525.1 Cr | -10.4% | -13.8% | -5.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | -0.1% | 3.4% | -0.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,614.0 Cr | 1.6% | -2.5% | 8.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,245.0 Cr | 0.8% | -0.9% | 13.5% | Stock Analytics | |
| CIPLA | ₹122,555.0 Cr | 1.3% | -0.6% | 3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,803.0 Cr | 1% | 3.7% | 2.7% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | -10.4% |
-13.8% |
-5.5% |
| SENSEX | -0.5% |
1% |
4.6% |
You may also like the below Video Courses